Vicki Roberts
Physician Assistant · West Columbia, SCNPI 1952379471
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (31.2%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Arcutis Biotherapeutics, Inc. at 36.4% of the total. Reporting peaked in 2024 at $23,133 and has fallen 65.3% since, to $8,022 in 2025. Among physician assistant clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,042 payments — averaging $73.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arcutis Biotherapeutics, Inc.$28K
- Sun Pharmaceutical Industries Inc.$17K
- EPI Health, LLC$5K
- AbbVie$3K
- Incyte Corporation$3K
- Sanofi$3K
- plus $18K from 27 others
What the payments were for
- Consulting fees$23,38530%
- Speaking & faculty fees$24,06831%
- Travel & lodging$5,8098%
- Food & beverage$23,82531%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 82 | $28,076 |
| Sun Pharmaceutical Industries Inc. | 90 | $17,251 |
| EPI Health, LLC | 25 | $4,594 |
| AbbVie | 137 | $3,197 |
| Incyte Corporation | 38 | $3,194 |
| Sanofi | 55 | $3,011 |
| E.r. Squibb & Sons, L.L.C. | 39 | $2,661 |
| Novartis | 65 | $2,573 |
| Dermavant Sciences, Inc. | 34 | $2,227 |
| Amgen | 53 | $1,314 |
| LEO Pharma Inc. | 53 | $1,255 |
| UCB, Inc. | 39 | $1,242 |
| Pfizer | 51 | $1,229 |
| Regeneron Healthcare Solutions, Inc. | 48 | $1,146 |
| Lilly USA, LLC | 44 | $877 |
| Galderma Laboratories, L.p. | 58 | $860 |
| Johnson & Johnson | 41 | $658 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 25 | $515 |
| Organon | 18 | $337 |
| Boehringer Ingelheim | 10 | $261 |
| Mayne Pharma Commercial LLC | 17 | $220 |
| VYNE Pharmaceuticals Inc. | 4 | $62 |
| Verrica Pharmaceuticals Inc. | 3 | $61 |
| Botanix SB Inc | 2 | $40 |
| Mylan Institutional Inc. | 2 | $40 |
| Smith+Nephew | 2 | $34 |
| Sanofi-aventis U.S. LLC | 1 | $28 |
| Fresenius Kabi USA, LLC | 1 | $26 |
| Biocon Biologics Inc | 1 | $24 |
| Sensus Healthcare, Inc. | 1 | $24 |
| Journey Medical Corporation | 1 | $18 |
| Kyowa Kirin, Inc. | 1 | $16 |
| Access Pro Medical, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$77,087 in reported general payments places this provider in the 95th percentile of 1,852 physician assistant providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OtezlaApremilast | 34 | $166,054 |
| Dupixent PenDupilumab | 22 | $133,305 |
| Humira PenAdalimumab | 12 | $78,091 |
| Clobetasol Propionate | 161 | $4,481 |
| Ketoconazole | 214 | $3,551 |
| Metronidazole | 67 | $2,674 |
| Triamcinolone Acetonide | 176 | $1,483 |
| Doxycycline Hyclate | 77 | $1,470 |
| Fluorouracil | 19 | $1,067 |
| Hydrocortisone | 206 | $997 |
| Betamethasone Dipropionate | 30 | $961 |
| Tretinoin | 18 | $845 |
| Clindamycin Phosphate | 34 | $675 |
| Ciclopirox | 20 | $619 |
| Mupirocin | 91 | $582 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenOtezla | $1,314 | $166,05434 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,852 physician assistant providers in South Carolina.
Other physician assistant in West Columbia
- Benjamin AddyWest Columbia$377K
- Andre KennedyWest Columbia$9K
- Michael OvercashCharleston$210K
- Allison LesterMt Pleasant$163K
- Nicole KeeterFort Mill$129K
- William YoungGreenville$117K
- Stephanie DavisAnderson$78K
- Eric ShoupColumbia$74K
- Lauren OlsonNorth Charleston$62K
- Martha GreenSummerville$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.